Your search returned 102 results.

Results
	1.	Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes. [electronic resource] by van Raalte, Daniël H Bjornstad, Petter Producer: 20200904 In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? [electronic resource] by van Raalte, Daniel H Diamant, Michaela Producer: 20120130 In: Diabetes research and clinical practice vol. 93 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest? [electronic resource] by van Raalte, Daniël H Verchere, C Bruce Producer: 20180507 In: Diabetes, obesity & metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Bariatric surgery and kidney disease outcomes in severely obese youth. [electronic resource] by Bjornstad, Petter Nehus, Edward van Raalte, Daniel Producer: 20201218 In: Seminars in pediatric surgery vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Glucagon-Like Peptide-1 Receptor Agonists: Beta-Cell Protection or Exhaustion? [electronic resource] by van Raalte, Daniël H Verchere, C Bruce Producer: 20171218 In: Trends in endocrinology and metabolism: TEM vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Sodium glucose cotransporter 2 inhibition and renal ischemia: implications for future clinical trials. [electronic resource] by van Raalte, Daniël H Cherney, David Z I Producer: 20190201 In: Kidney international vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Nephroprotective effects of GLP-1 receptor agonists: where do we stand? [electronic resource] by Mosterd, Charlotte M Bjornstad, Petter van Raalte, Daniël H Producer: 20210818 In: Journal of nephrology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	The authors reply. [electronic resource] by van Bommel, Erik J M van Raalte, Daniël H Producer: 20200831 In: Kidney international vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	About the gut microbiome as a pharmacological target in atherosclerosis. [electronic resource] by Witjes, Julia J van Raalte, Daniel H Nieuwdorp, Max Producer: 20160614 In: European journal of pharmacology vol. 763 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Renoprotection in diabetic kidney disease: can incretin-based therapies deliver? [electronic resource] by van Baar, Michaël J B van Raalte, Daniël H Producer: 20210208 In: Current opinion in nephrology and hypertension vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	ACE-I vs. ARB for blood pressure control in diabetic kidney disease. [electronic resource] by Tonneijck, Lennart Muskiet, Marcel H A van Raalte, Daniël H Producer: 20160301 In: Kidney international vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes. [electronic resource] by Heuvelman, Valerie D Van Raalte, Daniël H Smits, Mark M Producer: 20201019 In: Cardiovascular research vol. 116 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide. [electronic resource] by van Genugten, Renate E van Raalte, Daniël H Diamant, Michaela Producer: 20100423 In: Diabetes research and clinical practice vol. 86 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Liraglutide and Renal Outcomes in Type 2 Diabetes. [electronic resource] by Tonneijck, Lennart van Raalte, Daniël H Muskiet, Marcel H A Producer: 20171201 In: The New England journal of medicine vol. 377 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Letter by Muskiet et al Regarding Article, "Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial". [electronic resource] by Muskiet, Marcel H A Tonneijck, Lennart van Raalte, Daniël H Producer: 20151019 In: Circulation vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Pancreatic steatosis in humans: cause or marker of lipotoxicity? [electronic resource] by van Raalte, Daniël H van der Zijl, Nynke J Diamant, Michaela Producer: 20110105 In: Current opinion in clinical nutrition and metabolic care vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	SGLT2 inhibition: a new era in renoprotective medicine? [electronic resource] by Muskiet, Marcel H A Heerspink, Hiddo J L van Raalte, Daniël H Producer: 20180423 In: The lancet. Diabetes & endocrinology vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes. [electronic resource] by Muskiet, Marcel H A van Bommel, Erik Jm van Raalte, Daniël H Producer: 20160928 In: The lancet. Diabetes & endocrinology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. [electronic resource] by van Raalte, Daniel H Li, Min Pritchard, P Haydn Wasan, Kishor M Producer: 20050412 In: Pharmaceutical research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. [electronic resource] by Bouter, Kristien E van Raalte, Daniël H Groen, Albert K Nieuwdorp, Max Producer: 20170804 In: Gastroenterology vol. 152 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 102 results.